Celldex Therapeutics, Inc.
CLDX
$32.55
$0.551.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -78.69M | -81.32M | -67.04M | -56.60M | -53.80M |
| Total Depreciation and Amortization | 854.00K | 816.00K | 824.00K | 873.00K | 867.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.90M | 8.03M | 7.79M | 7.51M | 7.05M |
| Change in Net Operating Assets | 4.35M | 8.53M | 9.80M | 4.22M | -8.50M |
| Cash from Operations | -65.59M | -63.94M | -48.63M | -44.01M | -54.37M |
| Capital Expenditure | -1.64M | -1.28M | -440.00K | -728.00K | -265.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.76M | 56.71M | 61.29M | 50.58M | 43.22M |
| Cash from Investing | 72.12M | 55.43M | 60.85M | 49.85M | 42.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 327.00K | 1.35M | 774.00K | 63.00K | 202.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 327.00K | 1.35M | 774.00K | 63.00K | 202.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.86M | -7.17M | 12.99M | 5.91M | -11.22M |